ELVElevance Health, Inc.

NYSE elevancehealth.com


$ 526.95 $ 1.35 (0.26 %)    

Friday, 03-May-2024 15:59:54 EDT
QQQ $ 435.98 $ 8.58 (2.01 %)
DIA $ 386.87 $ 4.54 (1.19 %)
SPY $ 511.25 $ 6.26 (1.24 %)
TLT $ 89.88 $ 0.90 (1.01 %)
GLD $ 212.97 $ -0.17 (-0.08 %)
$ 526.96
$ 525.94
$ 0.00 x 0
$ 0.00 x 0
$ 518.89 - $ 528.31
$ 408.05 - $ 542.07
819,445
na
122.47B
$ 1.00
$ 19.61
TBD
na
na ($ 0.01)
na
TBD na
How to Read 10-K & 10-Q Reports To View SEC Filing Reports, Please Register or Sign In
# Filing Date Period End Date Type Report Link
1 04-18-2024 03-31-2024 10-Q
2 02-21-2024 12-31-2023 10-K
3 10-18-2023 09-30-2023 10-Q
4 07-19-2023 06-30-2023 10-Q
5 04-19-2023 03-31-2023 10-Q
6 02-15-2023 12-31-2022 10-K
7 10-19-2022 09-30-2022 10-Q
8 07-20-2022 06-30-2022 10-Q
9 04-20-2022 03-31-2022 10-Q
10 02-16-2022 12-31-2021 10-K
11 10-20-2021 09-30-2021 10-Q
12 07-21-2021 06-30-2021 10-Q
13 04-21-2021 03-31-2021 10-Q
14 02-18-2021 12-31-2020 10-K
15 10-28-2020 09-30-2020 10-Q
16 07-29-2020 06-30-2020 10-Q
17 04-29-2020 03-31-2020 10-Q
18 02-19-2020 12-31-2019 10-K
19 10-23-2019 09-30-2019 10-Q
20 07-24-2019 06-30-2019 10-Q
21 04-24-2019 03-31-2019 10-Q
22 02-20-2019 12-31-2018 10-K
23 10-31-2018 09-30-2018 10-Q
24 07-25-2018 06-30-2018 10-Q
25 04-25-2018 03-31-2018 10-Q
26 02-21-2018 12-31-2017 10-K
27 10-25-2017 09-30-2017 10-Q
28 07-26-2017 06-30-2017 10-Q
29 04-26-2017 03-31-2017 10-Q
30 02-22-2017 12-31-2016 10-K
31 11-02-2016 09-30-2016 10-Q
32 07-27-2016 06-30-2016 10-Q
33 04-27-2016 03-31-2016 10-Q
34 02-19-2016 12-31-2015 10-K
35 10-28-2015 09-30-2015 10-Q
36 07-29-2015 06-30-2015 10-Q
37 04-29-2015 03-31-2015 10-Q
38 02-24-2015 12-31-2014 10-K
39 10-29-2014 09-30-2014 10-Q
40 07-30-2014 06-30-2014 10-Q
Guide for Analyst Ratings To View Analyst Ratings, Please Register or Sign In
# Date Analyst Firm Upside/Downside Price Target Change Rating Change Current Rating

News

OPINIONS

 mizuho-maintains-buy-on-elevance-health-raises-price-target-to-585

Mizuho analyst Ann Hynes maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $575 to $585.

 tracking-last-weeks-top-performers-are-these-7-large-cap-stocks-in-your-portfolio-april-13-20-2024

Last week's top performers included United Airlines, Bentley Systems, Progressive Corp and Morgan Stanley.

 rbc-capital-maintains-outperform-on-elevance-health-raises-price-target-to-575

RBC Capital analyst Ben Hendrix maintains Elevance Health (NYSE:ELV) with a Outperform and raises the price target from $574...

 ubs-maintains-buy-on-elevance-health-raises-price-target-to-605

UBS analyst A.J. Rice maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $585 to $605.

 wells-fargo-maintains-overweight-on-elevance-health-raises-price-target-to-600

Wells Fargo analyst Stephen Baxter maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $...

 truist-securities-reiterates-buy-on-elevance-health-raises-price-target-to-600

Truist Securities analyst David Macdonald reiterates Elevance Health (NYSE:ELV) with a Buy and raises the price target from ...

 jefferies-maintains-buy-on-elevance-health-raises-price-target-to-604

Jefferies analyst David Windley maintains Elevance Health (NYSE:ELV) with a Buy and raises the price target from $602 to $604.

 barclays-maintains-overweight-on-elevance-health-raises-price-target-to-621

Barclays analyst Andrew Mok maintains Elevance Health (NYSE:ELV) with a Overweight and raises the price target from $584 to ...

 elevance-health-clocks-22b-q1-net-profit-despite-21-drop-in-medicaid-enrollment-lifts-annual-guidance

Elevance Health reports Q1 revenues at $42.3 billion, surpassing expectations. CEO Gail Boudreaux highlights strategic growth i...

 earnings-scheduled-for-april-18-2024

Companies Reporting Before The Bell • Addex Therapeutics (NASDAQ:ADXN) is estimated to report earnings for its fourth quarter.

 elevance-health-q1-2024-adj-eps-1064-beats-1053-estimate-sales-42273b-miss-42626b-estimate

Elevance Health (NYSE:ELV) reported quarterly earnings of $10.64 per share which beat the analyst consensus estimate of $10.53 ...

 see-how-floridas-much-awaited-medicaid-re-procurement-awards-impact-centene-humana-molina

Florida announces Medicaid contract awards to Centene, Elevance Health, and Humana, sidelining UnitedHealth, CVS Health, and Mo...

 elevance-health-cdr-announce-agreement-to-form-strategic-partnership-to-accelerate-primary-care-delivery

This effort, which will operate across multiple regions of the United States, will bring together certain care delivery and ena...

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION